Quality of Life in Children With Congenital Adrenal Hyperplasia: A Tertiary‐Center Case‐Control Study
Clinical Endocrinology · 2026
DOI: 10.1111/cen.70101 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Endocrinology, 2026. Verfasst von Özlem Nalbantoğlu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Endocrinology, University of Health Sciences, Dr. Behçet Uz Children's Hospital, İzmir, Turkey. Hauptthemen laut MEDLINE: Adrenal Hyperplasia, Congenital, Quality of Life. Die Arbeit nennt 21 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Congenital adrenal hyperplasia (CAH) is a chronic endocrine disorder affecting adrenal steroidogenesis, often requiring lifelong glucocorticoid therapy. Its impact on health‐related quality of life (HRQoL) in pediatric patients is inconsistent in the literature, with limited data from specific populations.
Objective
To compare HRQoL in children and adolescents with CAH to healthy peers, and to evaluate the influence of age, sex, ambiguous genitalia, and glucocorticoid dose.
Methods
This cross‐sectional case‐control study included 25 children and adolescents with CAH (aged 5–18 years) and 25 healthy controls frequency‐matched for age and sex. HRQoL was assessed using the Pediatric Quality of Life Inventory (PedsQL™ 4.0) via child self‐reports and parent proxy reports. Participants were grouped by age: 5–6, 7–12, and 13–18 years. Clinical data, including, presence of ambiguous genitalia, and glucocorticoid dose, were recorded.
Results
Overall, HRQoL scores were similar between CAH patients and controls. Age‐stratified analysis showed that children aged 7–12 years with CAH reported higher physical functioning ( p = 0.037) and total HRQoL ( p = 0.04) compared to controls. Adolescents with CAH reported significantly lower school functioning ( p = 0.03), while other domains were comparable. No significant differences in HRQoL were observed by sex, ambiguous genitalia, or glucocorticoid dose.
Conclusion
Children and adolescents with CAH generally achieve HRQoL comparable to healthy peers under adequate treatment. Age‐specific differences suggest younger children may experience preserved or enhanced physical well‐being, while adolescents are vulnerable to reduced school functioning. These findings highlight the need for multidisciplinary, age‐sensitive management strategies that include psychological and academic support, especially during adolescence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Endocrinology, University of Health Sciences, Dr. Behçet Uz Children's Hospital, İzmir, Turkey.
- Department of Child and Adolescent Psychiatry, University of Health Sciences, Dr. Behçet Uz Children's Hospital, İzmir, Turkey.
ORCID-Profile: Özge Köprülü, İbrahim Mert Erbaş, Gülşen Özer, Nagihan Cevher Binici
Zitieren
APA
Nalbantoğlu, Ö., Köprülü, Ö., Şimşek, F. Y., Erbaş, İ. M., Özer, G., Binici, N. C., & Özkan, B. (2026). Quality of Life in Children With Congenital Adrenal Hyperplasia: A Tertiary‐Center Case‐Control Study. Clinical Endocrinology. https://doi.org/10.1111/cen.70101
Vancouver
Nalbantoğlu Ö, Köprülü Ö, Şimşek FY, Erbaş İM, Özer G, Binici NC, et al. Quality of Life in Children With Congenital Adrenal Hyperplasia: A Tertiary‐Center Case‐Control Study. Clinical Endocrinology. 2026. doi:10.1111/cen.70101
BibTeX
@article{Nalbantolu2026,
author = {Nalbantoğlu, Özlem and Köprülü, Özge and Şimşek, Fatma Yavuzyılmaz and Erbaş, İbrahim Mert and Özer, Gülşen and Binici, Nagihan Cevher and Özkan, Behzat},
title = {Quality of Life in Children With Congenital Adrenal Hyperplasia: A Tertiary‐Center Case‐Control Study},
journal = {Clinical Endocrinology},
year = {2026},
doi = {10.1111/cen.70101}
}
EUVIMED